A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin

Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects

(2016) Pahweenvaj Ratnatilaka Na Bhuket et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Antinociceptive and anti-inflammatory effects of rosmarinic acid isolated from Thunbergia laurifolia Lindl.

(2014) Wanvisa Boonyarikpunchai et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer

(2012) Dona Sinha et al.   CURRENT DRUG TARGETS

Bioavailability of a Lipidic Formulation of Curcumin in Healthy Human Volunteers

(2012) Yogesh B. Pawar et al.   Pharmaceutics

Effects of Different Carboxylic Ester Spacers on Chemical Stability, Release Characteristics, and Anticancer Activity of Mono-PEGylated Curcumin Conjugates

(2011) Wisut Wichitnithad et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Synthesis, Characterization and Biological Evaluation of Succinate Prodrugs of Curcuminoids for Colon Cancer Treatment

(2011) Wisut Wichitnithad et al.   MOLECULES

Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies

(2010) Jenny Epstein et al.   BRITISH JOURNAL OF NUTRITION

Curcumin: From ancient medicine to current clinical trials

(2008) H. Hatcher et al.   CELLULAR AND MOLECULAR LIFE SCIENCES